The California First District Court of Appeal has held that drug manufacturers can be held liable for harm caused by a competitor's generic version of the same drug. The opinion is
available here.
For comments on the opinion go to these sites
Drug and Device Law
Law.com
Pharmalot
San Francisco Chronicle
No comments:
Post a Comment